JAZZ
Jazz Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · IE
$240.74
−1.27%Forward multiples
Based on analyst estimates
- P/E forward
- 9.56x
- P/E 2026E
- 9.56x
- P/E 2027E
- 9.29x
- P/E 2028E
- 8.24x
- P/S forward
- 3.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.84x
- PEG TTM
- 0.24x
- Price / book
- 3.25x
- Price / sales
- 3.40x
- Price / cash flow
- 9.41x
Enterprise value
- Enterprise value
- $17.8B
- EV / sales
- 3.88x
- EV / EBITDA
- 12.08x
- EV / EBIT
- 12.48x
- Market cap
- $15.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026